ABS VENTURES
Formed in 1982, ABS Ventures is a Boston-based venture capital firm backed by leading global institutional investors. The firm works with exceptional management teams to build industry leading companies in the software, communications and healthcare sectors. ABS Ventures provides more than just capital. The team brings to bear its collective operational and enterprise-building expertise as well as an extensive network of industry contacts. ABS Ventures works in partnership with management teams and believes that patience and a long term approach drive great performance.
ABS VENTURES
Industry:
Venture Capital
Founded:
1982-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Analytics Nginx Microsoft Exchange Online Google Maps Microsoft Azure DNS AJAX Libraries API PHP PHP 7 Google Analytics Classic GoDaddy SSL
Similar Organizations
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-11-26 | Aushon BioSystems | ABS Ventures investment in Venture Round - Aushon BioSystems | 8.01 M USD |
| 2012-11-29 | Melinta Therapeutics | ABS Ventures investment in Post-IPO Equity - Melinta Therapeutics | 67.5 M USD |
| 2012-01-09 | ClickSquared | ABS Ventures investment in Series C - ClickSquared | 9 M USD |
| 2011-02-23 | Centric Software | ABS Ventures investment in Series C - Centric Software | 7.5 M USD |
| 2010-07-19 | Zilliant | ABS Ventures investment in Venture Round - Zilliant | 13.1 M USD |
| 2010-04-19 | Overtone | ABS Ventures investment in Series C - Overtone | 7 M USD |
| 2009-10-01 | Overtone | ABS Ventures investment in Venture Round - Overtone | 2.5 M USD |
| 2009-06-09 | Wimba | ABS Ventures investment in Series C - Wimba | 6 M USD |
| 2009-04-19 | EverBridge | ABS Ventures investment in Series A - EverBridge | 2 M USD |
| 2009-01-25 | Melinta Therapeutics | ABS Ventures investment in Series D - Melinta Therapeutics | 25 M USD |